What Is Prostate Vaporization and How Does It Work?

Prostate vaporization is a surgical technique that uses intense heat to destroy overgrown prostate tissue, relieving urinary obstruction caused by benign prostatic hyperplasia (BPH). Rather than physically cutting and removing tissue the way traditional surgery does, vaporization converts prostate cells almost instantly into steam, opening a wider channel through the urethra so urine flows freely again. Several energy sources can accomplish this, from high-powered lasers to radiofrequency-generated water vapor, and the approach you encounter depends on your anatomy, your overall health, and what your urologist has available.

Why the Prostate Needs Treating in the First Place

BPH is the non-cancerous overgrowth of prostate tissue surrounding the urethra, and as that tissue expands it gradually squeezes the urinary channel shut.¹ The symptoms are familiar to millions of men over fifty: weak stream, frequent nighttime urination, difficulty starting, and the feeling that the bladder never fully empties. Medications work for many, but when pills stop controlling symptoms or side effects become intolerable, surgery enters the conversation. For decades the standard operation was transurethral resection of the prostate (TURP), which uses an electrified wire loop to carve tissue away. TURP is effective but requires general or spinal anesthesia, typically a multi-day hospital stay, and carries meaningful bleeding risk. Vaporization technologies were developed largely to get the same symptom relief with less blood loss, shorter hospital stays, and a gentler recovery.

How Laser Vaporization Works

The most widely studied version is photoselective vaporization of the prostate (PVP), marketed under the GreenLight brand. A thin fiber is threaded through the urethra and positioned inside the prostate. The fiber emits a high-power laser beam at a wavelength that is heavily absorbed by hemoglobin in the blood-rich prostate tissue.² That absorption converts laser energy to heat so rapidly that tissue water boils and the cells essentially explode into vapor. Because the laser is tuned to hemoglobin, blood vessels seal almost as fast as they open, which explains why bleeding during and after the procedure is dramatically lower than with conventional resection.³

The surgeon sweeps the fiber across the obstructing lobes in a painting motion, watching the tissue vanish in real time on a camera screen. Saline irrigation continuously flushes the vapor and debris, keeping the field clear. The whole procedure takes place through the natural urinary opening with no external incisions.

Other Energy Platforms

GreenLight is not the only game. Thulium fiber lasers operate at a slightly different wavelength and are strongly absorbed by water rather than hemoglobin, which gives them their own set of tissue-interaction characteristics. In laboratory testing, a thulium laser at 70 watts ablated tissue faster than a comparable GreenLight laser while producing a similarly low bleeding rate and a thinner coagulation zone.⁴ Higher-power thulium systems increase the vaporization rate further without deepening thermal penetration into surrounding tissue.⁵ A newer entrant, the blue laser (at roughly 450 nm), has shown advantages over GreenLight in shorter catheter time and faster early recovery, along with better sexual function preservation in men with medium-sized prostates.⁶

Bipolar plasma vaporization takes a completely different route. Instead of laser light, it uses an electrical current passed through saline to generate a plasma field on the surface of a specialized electrode. The plasma heats tissue to the point of vaporization while creating an extremely shallow thermal injury zone, measured in fractions of a millimeter.⁷ This approach uses the same resectoscope platform urologists already know from TURP, which lowers the equipment learning curve.

Water Vapor Therapy Is a Different Category

Rezūm, a transurethral water vapor therapy, often gets mentioned alongside laser vaporization, but the mechanism and setting are quite different. Rather than vaporizing tissue directly, Rezūm injects pulses of steam into the obstructing prostate lobes. The steam condenses inside the tissue, releasing stored thermal energy that destroys cells from within.⁸ Over the following weeks, the body reabsorbs the dead tissue and the channel opens up. A pilot study found that even a single steam injection per lobe provided symptom relief comparable to the traditional multi-injection approach.⁹

Because the tissue destruction happens gradually rather than in real time, Rezūm can be performed in an office setting under local anesthesia, making it attractive for men who want to avoid a trip to the operating room. The trade-off is that symptom improvement is not immediate; most men need several weeks before urine flow meaningfully improves. Rezūm also works for prostates with a prominent median lobe or elevated bladder neck.¹⁰

How Vaporization Compares to Traditional Resection

The comparison most men care about is GreenLight PVP versus TURP, because TURP has been the benchmark for decades. In a randomized trial, both procedures produced the same degree of improvement in symptom scores and urine flow at every follow-up point. But the safety profiles diverged sharply: none of the PVP patients needed a blood transfusion, while a fifth of the TURP patients did. No major intraoperative complications were recorded in the PVP group, whereas the TURP group saw capsule perforations and cases of fluid-absorption syndrome. Catheter time and hospital stay were both significantly shorter after PVP.¹¹

A systematic review and meta-analysis that pooled data from many such trials confirmed the pattern: TURP patients had over six times the risk of needing a blood transfusion. Catheter time and length of stay favored PVP. The two procedures were equivalent for urinary tract infections and the need for temporary re-catheterization. At two years the symptom scores and flow rates were close, though TURP showed a slight statistical edge on some measures. By five years, that edge widened modestly, and PVP carried a higher rate of reoperation for tissue regrowth or incomplete vaporization.¹² So the trade-off is real: vaporization buys a safer, faster recovery up front but may come with a somewhat higher chance of needing a second procedure years later.

Recovery and What to Expect Afterward

One of vaporization’s selling points is the speed of recovery. In a seven-year series of outpatient GreenLight procedures, the median hospital stay was about five hours and the catheter came out at roughly 48 hours on average.¹³ A randomized trial comparing PVP to TURP found catheter duration averaged about 13 hours for PVP versus nearly 45 hours for TURP, and hospital stay was about one day versus nearly four.¹⁴ Many centers now perform GreenLight PVP as a true day-surgery procedure.

That does not mean recovery is effortless. Urgency, frequency, and burning during urination are common in the first days to weeks as the vaporized cavity heals. A study tracking new-onset urge incontinence after PVP found that about 43% of men experienced it the first week, dropping to about 27% at one month, 14% at three months, and resolving entirely by six months.¹⁵ Blood-tinged urine can appear intermittently for several weeks, and most urologists advise avoiding heavy lifting and straining for at least two weeks.

Sexual Function After Vaporization

A major reason men hesitate over prostate surgery is concern about erections and ejaculation. The evidence for vaporization techniques is generally reassuring, though the answer depends on the specific procedure and technique used. A randomized trial of Rezūm water vapor therapy found that symptom scores and urine flow improved significantly while both erectile and ejaculatory function were preserved through one year of follow-up.¹⁶ A prospective study of blue laser vaporization likewise showed no significant changes in scores for erectile function, ejaculatory function, or sexual bother after surgery.¹⁷

Some surgeons have developed a modification called “ejaculatory hood-sparing” vaporization, which deliberately avoids vaporizing tissue near the verumontanum, the small ridge inside the urethra where the ejaculatory ducts open. In one study of this technique using GreenLight PVP, anterograde ejaculation (the normal forward direction) was preserved in 80% of patients, and scores for erection, ejaculation, and overall sexual satisfaction all improved at three months compared to baseline.¹⁸ A comparative study of the same sparing technique using either GreenLight or bipolar plasma energy found ejaculatory preservation rates of 85% and 78% respectively at six months.¹⁹ For context, standard TURP produces retrograde ejaculation (where semen goes backward into the bladder) in the majority of men, so the preservation rates with vaporization represent a real advantage.

Men on Blood Thinners

One population that benefits disproportionately from laser vaporization is men who take anticoagulants or antiplatelet medications. TURP requires stopping these drugs before surgery, which creates a dangerous window where strokes and heart attacks become more likely. Because the GreenLight laser seals blood vessels as it works, several groups have tested whether patients can safely stay on their blood thinners during the procedure.

A study of over 230 patients treated with GreenLight PVP found that bleeding rates were similarly low regardless of whether patients were on anticoagulants. Only about 4% experienced any intraoperative bleeding, and no patient in the study needed a blood transfusion.²⁰ A multicenter series specifically examining patients on newer oral anticoagulants reported no bleeding complications at all, including no clots, no significant blood in the urine, and no readmissions for bleeding.²¹ A meta-analysis concluded that PVP works comparably in patients on and off anticoagulants, suggesting that high-risk patients may not need to stop their blood thinners for the procedure.²²

Does Prostate Size Matter?

TURP has traditionally been considered less suitable for very large prostates because the operating time stretches out and fluid absorption becomes riskier. Vaporization faces a different constraint: large glands simply take longer to vaporize, and there is more tissue that could potentially regrow. Still, studies have shown strong results in men with prostates averaging about 100 cubic centimeters, well above the typical range. In one series, symptom scores dropped by more than half within a month and urine flow roughly doubled, with no transfusions required and virtually all patients going home within 23 hours.²³

Anatomy matters as much as raw volume. A prominent median lobe, the tongue of tissue that projects upward into the bladder, can act like a ball valve and is a common cause of severe obstruction. Data from a large international registry found that GreenLight PVP in men with a median lobe added only about seven extra minutes of operative time and produced equivalent functional outcomes compared to men without one. In fact, men with a median lobe had a slightly greater drop in symptom scores at one year.²⁴ A separate study with four years of follow-up confirmed that improvement was actually more pronounced and longer-lasting in the median-lobe group.²⁵

How Long Does It Last?

Durability is where vaporization has attracted the most honest criticism. Because the tissue is vaporized rather than removed and sent to the lab, the prostate can regrow into the cavity over time. A study tracking men for a full decade after GreenLight PVP found that symptom scores, quality of life, and PSA levels remained significantly better than before surgery even at ten years. However, urine flow rate and post-void residual volume were no longer statistically improved at that point. The retreatment-free survival rate was about 94% at five years and 79% at ten years.²⁶ Another large series reported an overall retreatment rate of about 18%, with most reinterventions happening within the first year. A poor urine flow immediately after catheter removal was identified as the strongest predictor of needing a redo.²⁷

For Rezūm water vapor therapy, the data horizon is shorter but growing. A prospective study following over 200 men for up to three years found that about 86% achieved a meaningful improvement in symptom scores and about 93% reached a meaningful improvement in quality of life.²⁸ Rezūm was also tested specifically in men with urinary retention who were catheter-dependent. At six months, symptom scores dropped dramatically (from 17 to 4), peak flow doubled, and the residual urine volume plunged from 900 to 78 milliliters.²⁹ Longer follow-up data will be needed to compare Rezūm’s reoperation curve to what has been established for laser vaporization.

Late Complications Worth Knowing About

Besides the early irritative symptoms already mentioned, two late complications deserve attention. Urethral stricture, a scarring that narrows the urethra itself, can develop after any transurethral procedure. One study found that using warm irrigation fluid during a combined resection-and-vaporization procedure cut the six-month stricture rate from about 21% to about 6%.³⁰ Longer operative time and larger prostate volume have been identified as independent risk factors for stricture and bladder neck contracture after transurethral procedures.³¹ The meta-analysis comparing GreenLight to TURP found no difference between the two in rates of urethral stricture or bladder neck contracture, suggesting that the stricture risk is inherent to working through the urethra rather than specific to the energy source.¹²

Cost Differences

Laser equipment is expensive, which has been the main argument against broader adoption of vaporization. But total episode-of-care cost often favors PVP because the savings from shorter hospital stays and fewer transfusions offset the hardware price. A Canadian cost analysis found total per-patient costs of roughly $3,800 for GreenLight PVP versus about $5,000 for either monopolar or bipolar TURP.³² A U.S. analysis reached a similar conclusion, with average overall costs about $800 lower for laser vaporization.³³ A British health-economics study found that quality-of-life outcomes between PVP and TURP were nearly equivalent, and that PVP becomes cost-saving outright if more than about a third of cases can be performed as day surgery.³⁴ Since most high-volume centers now do exactly that, the economic case has only strengthened.

The Learning Curve for Surgeons

One practical factor that influences your outcome is how experienced your surgeon is with the specific platform. A multicenter study analyzing GreenLight PVP learning curves found that more than 100 procedures were needed before a surgeon’s intraoperative efficiency plateaued, regardless of their prior surgical background or institution type.³⁵ That is a steep curve compared to many urological procedures, and it means early outcomes at a center just adopting the technology may not match the results from high-volume published series. If you are considering vaporization, asking how many procedures your surgeon has performed is a reasonable and informative question. Surgeons who have passed the 100-case threshold tend to vaporize more tissue per minute, use less total energy, and have shorter operative times, all of which translate into fewer complications and better symptom relief for you.